<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000999'>Pyoderma</z:hpo> Gangrenosum (PG) is often associated with an underlying disease </plain></SENT>
<SENT sid="1" pm="."><plain>PG as a paraneoplastic disease is illustrated by the presentation of four patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> of myeloproliferative origin and PG </plain></SENT>
<SENT sid="2" pm="."><plain>An associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> is found in approximately 7% of patients with PG, most commonly haematologic in nature and in particular <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Clinically the PG is often of the superficial bullous variant and is associated with a poor prognosis </plain></SENT>
</text></document>